Session I: Introduction to Cancer Immunotherapy
Welcome, Introduction, SITC Resources
Basic Principles of Cancer ImmunotherapyPamela S. Ohashi, PhD – Princess Margaret Cancer Centre
Session II: Immunotherapy in Practice
Immunotherapy for the Treatment of Skin CancersElaine McWhirter, MD, MSc – Hamilton Health Sciences
Immunotherapy for the Treatment of Lung CancerAdrian G. Sacher, MD, MMSc – Princess Margaret Cancer Center
Immunotherapy for the Treatment of Head and Neck CancersMartin Smoragiewicz, MD.CM, PhD, FRCPC – Sunnybrook Health Sciences Centre
Immunotherapy for the Treatment of Genitourinary MalignanciesTBD
Immunotherapy for the Treatment of Hematologic MalignanciesStephen Ronan Foley, MD, FRCPC – Hamilton Health Sciences
Immunotherapy for the Treatment of Additional Solid Tumors: Gynecological CancersStephanie Lheureux, MD, PhD – Princess Margaret Cancer Centre
Session III: Immunotherapy Challenges and Beyond
6:30 p.m.–7:05 p.m.
Toxicity ManagementMateya Trinkaus, MD – Markham Stouffville Hospital
Practical Barriers in Cancer ImmunotherapyTBD
What's next for cancer immunotherapy?Marcus O. Butler, MD – Princess Margaret Cancer Centre
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE-, CNE-, MOC-certified programs.
Presented by leading and local authorities in tumor immunology and cancer immunotherapy, at the conclusion of this activity, participants of this should be able to:
Participation in this free, CME-, CPE-, CNE- and MOC-certified online pre-program course is strongly recommended as it contains information that will not be covered at the program. This updated, interactive course provides foundational knowledge that is necessary for understanding cancer immunotherapy content that will be discussed at the in-person program.Click here to access the course.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org